The Oncosearch | Oncotarget

Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence Research Paper

Kavin Sugumar, Andrew Alabd, Andre Alabd, Jonathan J. Hue, Josh Lyons, Sherri Fields, Zev Wainberg, Lei Zheng, Brianna Coogle, Anup Kasi, Nicholas Grewal, Hedy L. Kindler, Jason Starr, Ashwin R. Sama, Jordan M. Winter

Published Jun 3, 2025 · Vol. 16, No. 1 · pp. 427-442

Keywords: pancreatic adenocarcinoma, immunotherapy, exceptional responders, microsatellite instability, survival

Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management Research Paper

Scott Strum, Mark Vincent, Meghan Gipson, Eric McArthur, Daniel Breadner

Published Feb 28, 2024 · Vol. 15, No. 1 · pp. 381-388

Keywords: tumor marker, biomarker, lung cancer, NSCLC, translational research

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Addendum

Ellery Altshuler, Raymond Richhart, William King, Mahmoud Aryan, Akash Mathavan, Akshay Mathavan, Keegan Hones, Daniel F. Leach III, Logan Pucci, Joshua Riklan, Pat Haley, Ilyas Sahin, Brian Ramnaraign, Sherise Rogers, Ibrahim Nassour, Steven Hughes, Thomas J. George, Jesus Fabregas

Published Aug 28, 2023 · Vol. 14, No. 1 · pp. 971-971

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Research Paper

Ellery Altshuler, Raymond Richhart, William King, Mahmoud Aryan, Akash Mathavan, Akshay Mathavan, Keegan Hones, Daniel F. Leach III, Logan Pucci, Joshua Riklan, Pat Haley, Ilyas Sahin, Brian Ramnaraign, Sherise Rogers, Ibrahim Nassour, Steven Hughes, Thomas J. George, Jesus Fabregas

Published Apr 4, 2023 · Vol. 14, No. 1 · pp. 351-357

Keywords: duodenal adenocarcinoma, carbohydrate antigen, CA 19-9, carcinoembrionic antigen, CEA

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

Phyllis A. Gimotty, Jacob E. Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael J. LaRiviere, Mark H. O’Hara, Kim A. Reiss, Peter O'Dwyer, Bryson W. Katona, Daniel Herman, Erica L. Carpenter, Kenneth S. Zaret

Published Oct 15, 2021 · Vol. 12, No. 22 · pp. 2266-2272

Keywords: pancreatic cancer, metastasis, biomarkers, prognosis, THBS2

The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis Research Paper

Nivaldo Faria Vieira, Luciano Neder Serafini, Paulo Cezar Novais, Fermino Sanches Lizarte Neto, Mucio Luiz de Assis Cirino, Rafael Kemp, José Celso Ardengh, Fabiano Pinto Saggioro, Alberto Facury Gaspar, Ajith Kumar Sankarankutty, Jorge Resende Lopes Júnior, Daniela Pretti da Cunha Tirapelli, José Sebastião dos Santos

Published Jul 30, 2021 · Vol. 12, No. 17 · pp. 1638-1650

Keywords: pancreatic cancer, microRNA, CA19-9, biomarkers, cancer recurrence

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers Research Paper

Takeyuki Suzuki, Tetsutaro Suzuki, Yukino Yoshimura, Mitsunori Yahata, Poh Yin Yew, Tetsuya Nakamura, Yusuke Nakamura, Jae-Hyun Park, Ryota Matsuo

Published Jul 15, 2020 · Vol. 11, No. 34 · pp. 3198-3207

Keywords: ctDNA, early detection, liquid biopsy, mutation, recurrence

An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma Priority Research Paper

Katherine M. Bever, Erkut H. Borazanci, Elizabeth A. Thompson, Jennifer N. Durham, Kimberly Pinero, Gayle S. Jameson, Amber Vrana, Meizheng Liu, Cara Wilt, Annie A. Wu, Wei Fu, Hao Wang, Yafu Yin, Jeffrey P. Leal, Ana De Jesus-Acosta, Lei Zheng, Daniel A. Laheru, Daniel D. Von Hoff, Elizabeth M. Jaffee, Jonathan D. Powell, Dung T. Le

Published Apr 23, 2020 · Vol. 11, No. 21 · pp. 1929-1941

Keywords: pancreatic cancer, mTOR inhibition, maintenance therapy, metformin

Prognostic and predictive factors in pancreatic cancer Review

Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini

Published Mar 10, 2020 · Vol. 11, No. 10 · pp. 924-941

Keywords: metastatic pancreatic cancer, predictive and prognostic factors, CA19-9, gemcitabine-abraxane, FOLFIRINOX

Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC) Research Paper

Marta Åukaszewicz-ZajÄ…c, Mariusz Gryko, Sara PÄ…czek, Maciej Szmitkowski, BogusÅ‚aw KÄ™dra, Barbara Mroczko

Published Jan 8, 2019 · Vol. 10, No. 3 · pp. 395-403

Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker Research Paper

Neus Martinez-Bosch, Luis E. Barranco, Carlos A. Orozco, Mireia Moreno, Laura Visa, Mar Iglesias, Lucy Oldfield, John P. Neoptolemos, William Greenhalf, Julie Earl, Alfredo Carrato, Eithne Costello, Pilar Navarro

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32984-32996

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

Nicolas Williet, Thomas Di Bernardo, ChloÃ© Vernet, LÃ©a Saban Roche, Thierry Muron, Xavier Roblin, Nicolas Magne, Jean-Marc Phelip

Published Aug 10, 2018 · Vol. 9, No. 62 · pp. 31999-32009

Liquid biopsy in pancreatic cancer: the beginning of a new era Review

Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen, Tingbo Liang

Published Jun 1, 2018 · Vol. 9, No. 42 · pp. 26900-26933

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma Research Paper

Anne Aarnink, Corentin Richard, Caroline Truntzer, Julie Vincent, Leila Bengrine, AngÃ©lique Vienot, Christophe Borg, Francois Ghiringhelli

Published May 22, 2018 · Vol. 9, No. 39 · pp. 25617-25629

Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma Research Paper

Keith Unger, Khyati Y. Mehta, Prabhjit Kaur, Yiwen Wang, Smrithi S. Menon, Shreyans K. Jain, Rose A. Moonjelly, Shubhankar Suman, Kamal Datta, Rajbir Singh, Paul Fogel, Amrita K. Cheema

Published May 1, 2018 · Vol. 9, No. 33 · pp. 23078-23090

Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA Research Paper

Martin Zaleski, Makbule Kobilay, Lars Schroeder, Manuel Debald, Alexander Semaan, Karina Hettwer, Steffen Uhlig, Walther Kuhn, Gunther Hartmann, Stefan Holdenrieder

Published Apr 27, 2018 · Vol. 9, No. 32 · pp. 22523-22536

An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy Case Report

Bruno Christian KÃ¶hler, Benjamin Goeppert, Nina Waldburger, Kai Schlamp, Peter Sauer, Dirk JÃ¤ger, Karl Heinz Weiss, Stephan Macher-GÃ¶ppinger, Henning Schulze-Bergkamen, Peter Schirmacher, Christoph Springfeld

Published Apr 24, 2018 · Vol. 9, No. 31 · pp. 22230-22235

Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis Research Paper

Joy Cuenco, Natascha Wehnert, Oleg Blyuss, Anna Kazarian, Harry J. Whitwell, Usha Menon, Anne Dawnay, Michael P. Manns, Stephen P. Pereira, John F. Timms

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17430-17442

Significant increased CA199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer Research Paper

Dongling Teng, Keyan Wu, Yunyun Sun, Min Zhang, Dan Wang, Jian Wu, Tao Yin, Weijuan Gong, Yanbing Ding, Weiming Xiao, Guotao Lu, Weiqin Li

Published Jan 4, 2018 · Vol. 9, No. 16 · pp. 12745-12753

Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer Research Paper

Seiichi Shinji, Yoshibumi Ueda, Takeshi Yamada, Michihiro Koizumi, Yasuyuki Yokoyama, Goro Takahashi, Masahiro Hotta, Takuma Iwai, Keisuke Hara, Kohki Takeda, Mikihiro Okusa, Hayato Kan, Eiji Uchida

Published Dec 20, 2017 · Vol. 9, No. 2 · pp. 2553-2564

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence Research Paper

Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management Research Paper

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Addendum

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Research Paper

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis Research Paper

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers Research Paper

An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma Priority Research Paper

Prognostic and predictive factors in pancreatic cancer Review

Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC) Research Paper

Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker Research Paper

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

Liquid biopsy in pancreatic cancer: the beginning of a new era Review

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma Research Paper

Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma Research Paper

Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA Research Paper

An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy Case Report

Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis Research Paper

Significant increased CA199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer Research Paper

Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence Research Paper

Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management Research Paper

Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Addendum

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Research Paper

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma Research Paper

The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis Research Paper

Detection of circulating tumor DNA in patients of operative colorectal and gastric cancers Research Paper

An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma Priority Research Paper

Prognostic and predictive factors in pancreatic cancer Review

Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC) Research Paper

Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker Research Paper

Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progression-free survival and time without treatment in patients with locally advanced pancreatic cancers Research Paper

Liquid biopsy in pancreatic cancer: the beginning of a new era Review

Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma Research Paper

Metabolomics based predictive classifier for early detection of pancreatic ductal adenocarcinoma Research Paper

Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA Research Paper

An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy Case Report

Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis Research Paper

Significant increased CA199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer Research Paper

Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer Research Paper